Applications Published 30 May 2001
Published: 8-Mar-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
A new analgesic, anti-inflammatory and wound healing agent
Epigenesis Pharmaceutical 1102578* Medicinal aerosol formulations
Jago Research 1102579*Formulations having probiotically active microorganisms
Vierstein, Helmut 1102580*A microemulsion forming compsn for sustainted release of an active agent
Gatterfosse 1102581*Inhibitors of type 3,3 alpha-hydroxysteroid dehydrogenase
Endorecherche 1102582*Treatment of addiction and addiction-related behaviour
Brookhaven Science Associates 1102583*Antioxidant, antiproliferous compsn, comprising a carnitine and a carotenoid
Sigma-Tau Healthscience 1102584*Use of a cyclopentabenzofuran-derivatives for combating NF(K)B-dependent diseases
Bayer 1102585*Use of Ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
Societe de Conseils de Recherche et d'Applications Scientifiques 1102586* Vitronectin receptor antagonists
SmithKline Beecham 1102587*Pharmaceutival compsns for the prevention and treatment of central nervous system disorders
Targacept 1102588*Topical compsns comprising an opioid analgesic and an NMDA antagonist
Memorial Sloan-Kettering Institute for Cancer Research 1102589*Use of NK-1 receptor antagonist for treating or preventing abnormal bone resorption Merck Sharp & Dohme 1102590*Compsns containing phytosterol, phytostanol or mixtures of both and omega-3 fatty acids or derivatives thereof and use of the compsn in treating or preventing cardiovascular disease and other disorders
Forbes Medi-Tech 1102591*Delivery modification for radiation therapy
Wisconsin Alumni Research Foundation 1102611*Glucocorticoid and thyroid hromone receptor ligands for the treatment of metabolic disorders
Karo Bio 1102739*Compounds and compsns for delivering active agents
Emisphere Technologies 1102742*Amide derivatives which are useful as cytokine inhibitors
AstraZeneca 1102743* Novel method for preparing optically-active alpha-aminonitriles
Aventis Cropscience 1102744* A process for the preparation of zofenopril calcium salt
Menarini Richerche 1102745*Subtituted phenylamidines with anti-thrombitic action
Boehringer Ingelheim 1102746*Crustalline forms of osanetant
Sanofi-Synethelabo 1102747*New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
Arzneimittelwerk Dresden 1102748*Method for producing 2-halogen nicotinic acid derivatives and 2-chloronicotinic acid derivatives and 2-chloronicotinic acid-N-butyl esters as intermediate prodicts
BASF 1102749*Amide derivatives useful as inhibitors of the production of cytokines
AstraZeneca 1102750*Novel bi- and tri-cyclic aza compounds and their uses
Georgetown University 1102751*Succinoylaminolactams as inhibitors of a beta-protein production
Du Pont Pharmaceuticals 1102752*Pyrazoles as estrogen receptor modulators
Chiron Corp 1102753*Imidazoles and related compounds as alpha-1A agonists
Abbott Laboratories 1102754*Substituted isoxazole derivatives as estrogen receptor modulators
Chiron Corp 1102755*Aza-heterocyclic compounds used to treat neurological disorders and hair loss
GPI NIL Holdings 1102756*Substituted oxazole and thiazole derivatives as HPPAR gamma and HPPAR alpha activators
Glaxo Group 1102757*Particle-forming compsns containing fused pyrrazolocarbazoles
Cephalon 1102758*Methods for synthesis of substituted tetrahydrofuran compound
Millennium Pharmaceuticala 1102759*Process for the oxidation of butadiene and butene with cobalt and molybdenum oxide based catalysts
EI du Pont de Nemours 1102760*Cyclopentabenzofuran derivatives and their uses
Bayer 1102761*2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists
Pfizer 1102762*FSH mimetics for the treatment of infertility
Applied Research Systems 1102763*Paroxetine salts
SmithKline Beecham 1102764*
